Optellum, Johnson & Johnson Launch Strategic Collaboration in Lung Cancer
September 26th 2021Optellum and the Lung Cancer Initiative at Johnson & Johnson plan to use Optellum’s artificial intelligence-based decision support software in an effort to increase lung cancer survival rates via disease prevention and early intervention.